Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 3/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.48 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6329715 | 0.95 | LTA4H (0.54) | KDM4ESMN1; SMN2LTA4HFAAHALDH1A1 | |
| SCHEMBL21991820 | 0.90 | LTA4H (0.55) | KDM4ESMN1; SMN2LTA4HFAAHALDH1A1 | |
| SCHEMBL4275826 | 0.90 | HDAC1 (0.56) | LTA4HALDH1A1LMNAMAPTHTT | |
| SCHEMBL9034669 | 0.85 | L3MBTL1 (0.59) | LTA4HALDH1A1HPGDLMNAMAPT | |
| SCHEMBL14566050 | 0.85 | MAPT (0.56) | SMN1; SMN2ALDH1A1HPGDLMNAMAPT | |
| SCHEMBL5493279 | 0.84 | LTA4H (0.53) | KDM4ESMN1; SMN2LTA4HFAAHMAPT | |
| SCHEMBL809948 | 0.83 | NR5A1 (0.59) | LTA4HALDH1A1LMNAMAPTHTT | |
| SCHEMBL810018 | 0.83 | PPARD (0.53) | LTA4HALDH1A1LMNAMAPTHTT | |
| SCHEMBL21260769 | 0.83 | L3MBTL1 (0.57) | ALDH1A1HPGDLMNAMAPTHTT | |
| SCHEMBL14163893 | 0.83 | L3MBTL1 (0.57) | ALDH1A1HPGDLMNAMAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6867023-B2 | Production method of polyhydroxyalkanoate from substituted fatty acid ester as raw material | CANON KABUSHIKI KAISHA (JP) | 2005-03-15 | — | — | US | claimed |
| US-20020081646-A1 | Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material | CANON KABUSHIKI KAISHA (JP) | 2002-06-27 | — | — | US | claimed |
| EP-1201763-A2 | Production method of polyhydroxyalkanoate from substituted fatty acid ester as raw material | CANON KABUSHIKI KAISHA (JP) | 2002-05-02 | — | — | EP | claimed |
| US-6867023-B2 | Production method of polyhydroxyalkanoate from substituted fatty acid ester as raw material | CANON KABUSHIKI KAISHA (JP) | 2005-03-15 | — | — | US | disclosed |
| US-20020081646-A1 | Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material | CANON KABUSHIKI KAISHA (JP) | 2002-06-27 | — | — | US | disclosed |
| EP-1201763-A2 | Production method of polyhydroxyalkanoate from substituted fatty acid ester as raw material | CANON KABUSHIKI KAISHA (JP) | 2002-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020081646-A1 | Production method of polyhydroxyalkanoate form substituted fatty acid ester as raw material | FASN, FFAR1, ACADM | KDM4E 1818/4885SMN1; SMN2 4772/4885LTA4H 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.